Biomerica enrolls 1st patient in IBS diagnostic guided therapy — 5 insights

Biomerica enrolled the first patient in a clinical trial for its InFoods diagnostic-guided therapy to alleviate irritable bowel syndrome symptoms.

Here's what you should know:

1. Researchers are launching a randomized, double-blind, placebo-controlled clinical trial to test the effectiveness of Biomerica's IBS therapy.

2. The InFoods IBS product allows physicians to identify specific foods that impact a patient's IBD. If approved, physicians will be able to take a finger stick blood sample to find foods that impact IBS.

3. The study is being conducted at Boston-based Beth Israel Deaconess Medical Center and Ann Arbor-based University of Michigan.

4. The trial will include 180 patients and last up to 14 months.

5. The study results will be used in a FDA 510(k) application seeking FDA approval for the therapy.

Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Learning Opportunities

Featured Webinars

Featured Whitepapers

Featured Podcast